{"transactions":[{"id":858978,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":62603,"kind":"person","name":"Sy Jennifer","position":1,"cik":"0002023998","reported_name":"Sy Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-05T18:06:25.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":925925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents outstanding cash-settled restricted stock units granted on May 21, 2025 (the \"Grant Date\") that were modified on March 4, 2026 to be settled in stock instead of cash upon vesting. The restricted stock units continue to vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date. The restricted stock units were originally reported in Table II on a Form 4 filed on May 23, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents outstanding cash-settled restricted stock units granted on May 21, 2025 (the \"Grant Date\") that were modified on March 4, 2026 to be settled in stock instead of cash upon vesting. The restricted stock units continue to vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date. The restricted stock units were originally reported in Table II on a Form 4 filed on May 23, 2025."}],"balance_after":1501176,"source":{"system":"sec-edgar","filing":"0001104659-26-024231","document":"tm268148-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023998/000110465926024231/tm268148-1_4seq1.xml","form_type":"4"}},{"id":858977,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":62603,"kind":"person","name":"Sy Jennifer","position":1,"cik":"0002023998","reported_name":"Sy Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-05T18:06:25.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":575000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of restricted stock units granted on February 17, 2026 (the \"Grant Date\"), which vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units granted on February 17, 2026 (the \"Grant Date\"), which vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date."}],"balance_after":575251,"source":{"system":"sec-edgar","filing":"0001104659-26-024231","document":"tm268148-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023998/000110465926024231/tm268148-1_4seq1.xml","form_type":"4"}},{"id":1135664,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":62603,"kind":"person","name":"Sy Jennifer","position":1,"cik":"0002023998","reported_name":"Sy Jennifer","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2025-05-23T16:55:36.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":925925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") will be settled in cash based on the fair market value of the Issuer's Class A Common Stock on the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the RSUs shall vest on each anniversary of May 21, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"25% of the RSUs shall vest on each anniversary of May 21, 2025."}],"balance_after":925925,"derivative":{"underlying":"Class A Common Stock","underlying_shares":925925},"source":{"system":"sec-edgar","filing":"0001610717-25-000135","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023998/000161071725000135/form4.xml","form_type":"4"}},{"id":1416211,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":62603,"kind":"person","name":"Sy Jennifer","position":1,"cik":"0002023998","reported_name":"Sy Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Stock Option","published_at":"2024-09-04T21:53:47.000Z","date":"2024-08-31","kind":"grant","planned":false,"acquired":true,"shares":48063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of stock options granted on August 31, 2024 (the \"Grant Date\"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents an award of stock options granted on August 31, 2024 (the \"Grant Date\"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":48063,"derivative":{"exercise_price":0.83,"expiration_date":"2034-08-30","underlying":"Class A Common Stock","underlying_shares":48063},"source":{"system":"sec-edgar","filing":"0001104659-24-097062","document":"tm2423415-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023998/000110465924097062/tm2423415-4_4seq1.xml","form_type":"4"}},{"id":1416210,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":62603,"kind":"person","name":"Sy Jennifer","position":1,"cik":"0002023998","reported_name":"Sy Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-09-04T21:53:47.000Z","date":"2024-08-31","kind":"grant","planned":false,"acquired":true,"shares":18010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units granted on August 31, 2024 (the \"Grant Date\"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":18010,"source":{"system":"sec-edgar","filing":"0001104659-24-097062","document":"tm2423415-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023998/000110465924097062/tm2423415-4_4seq1.xml","form_type":"4"}}]}